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The papillomavirus E2 protein contains an amino-terminal region thought necessary and sufficient to support transcrip-
tional activation and a carboxy-terminal region shown to direct sequence-specific DNA binding and dimerization. A cysteine
residue in the center of the E2 DNA recognition helix is highly conserved among papillomavirus E2 proteins. Mutations of
this cysteine in bovine papillomavirus type 1 E2 to serine and glycine resulted in proteins which failed to activate E2-
dependent promoters in mammalian cells. These E2 mutants were DNA-binding competent, dimeric, and nuclear. When
fused to the VP16 transactivation domain, C-terminal regions of E2 containing the mutations at 340 supported transcriptional
activation, indicating that the heterologous trans-activation domain did not require cysteine in the DNA-binding helix as did
the full-length E2 transactivating protein. Although cysteine-340 was required for transcriptional activation it was not required
for DNA replication in vivo. Together, these results suggest that the E2 DNA-binding domain may directly contribute to
functions of transcriptional activation previously thought limited to the N-terminal domain. q 1996 Academic Press, Inc.
INTRODUCTION genotypes sequenced to date (Myers, 1994). This region
has been shown through biochemical and genetic stud-
The products of the papillomavirus (PV) E2 open read-
ies to mediate sequence-specific DNA binding (Moska-
ing frame (ORF) modulate viral gene expression through
luk and Bastia, 1988; Prakash et al., 1992). A high-resolu-
the activities of an activating protein (E2TA) and two re-
tion structure of the C-terminal 85 amino acids of BPV-1pressor proteins (E2TR, E8/E2) (for review see McBride
E2 bound to DNA showed the C-terminus folded into aet al., 1991). All three proteins share the carboxy-terminal
dimeric ‘‘b-barrel’’ with each E2 monomer contributing adomain which mediates both sequence-specific DNA
short a-helix (amino acids 336–342) extending acrossbinding and dimerization (Dostatni et al., 1988; Hawley-
the surface of the barrel (Hegde et al., 1992). These twoNelson et al., 1988; McBride et al., 1988, 1989; Moskaluk
a-helices lie in the major groove of DNA, forming multipleand Bastia, 1989; Monini et al., 1991). Only the transcrip-
ionic and hydrophobic bonds to the nucleotide core andtional activating form of the E2 protein (E2TA) contains
phosphate backbone. This structure places the con-the complete N-terminal transactivation domain (Giri and
served cysteine 340 in the center of the a-helix andYaniv, 1988; Haugen et al., 1988; McBride et al., 1989). E2
shows its sulfhydryl group donating a hydrogen bond tobinds DNA as a dimer to the palindrome ACCGN4CGGT
the G (/5) and accepting a hydrogen bond from the Awhich is found in promoter regions of PV genomes and
(06) of the ACCGN4CGGT inverted palindrome (Hegdein the origin of viral replication (Androphy et al., 1987;
et al., 1992). The binding-region cysteine of BPV-1 andSpalholz et al., 1987; Dostatni et al., 1988; Li et al., 1989;
HPV-16 E2 has been shown to confer oxidation/reductionMcBride et al., 1989; Moskaluk and Bastia, 1989). Binding
(redox) sensitivity to DNA-binding activity in vitroof E2 to this palindromic site presumably facilitates the
(McBride et al., 1992; Androphy and Pepinsky, unpub-assembly of cellular factors required for viral transcrip-
lished observations). Oxidized wild-type BPV-1 E2 willtion and replication.
not bind DNA in vitro but DNA binding can be reactivatedPapillomavirus E2 proteins share a common region of
by addition of reducing agents (dithiothreitol) (McBridebasic amino acids [aa 336 –344 in bovine papillomavirus
et al., 1992; Androphy and Pepinsky, unpublished obser-type 1 (BPV-1) E2] with a central cysteine (aa 340 in BPV-
vations).1) (McBride et al., 1989). The cysteine at this position in
DNA binding by the E2 C-terminal region is thoughtthe DNA-binding domain is conserved in 42 of 45 PV
necessary for in vivo DNA replication (Ustav and Sten-
lund, 1991; Yang et al., 1991; Ustav et al., 1993). Replica-1 To whom correspondence and reprint requests should be ad-
tion of the BPV-1 genome has been shown to requiredressed at Dept. of Dermatology, New England Medical Center, 750
Washington St., Box 166, Boston, MA 02111. three viral elements: an origin of replication (ori) present
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within the long control region (LCR) and the full-length visiae expression vector containing a 2m replicon and
the GAL 1-10 UAS (Morrissey et al., 1989). Mutationsproducts of the E1 and E2 ORFs (Ustav and Stenlund,
1991; Ustav et al., 1991; Yang et al., 1991; Ustav et al., were confirmed by DNA sequencing of the entire DNA-
binding region. The yeast reporter construct contained1993). The E1 protein contains ATPase, DNA helicase,
and ori-specific DNA-binding activities (Ustav and Sten- four E2-binding sites upstream of the lacZ gene. Two
expression vectors, pBG331 and pCG, were used to ex-lund, 1991; Wilson and Ludes-Meyers, 1991; Yang et al.,
1991; Seo et al., 1993). The E2TA protein complexes with amine E2 in mammalian cells. pBG331E2 contains the
BPV-1 E2 open reading frame (nucleotides 2600–4450)E1 and is believed to enhance E1 binding to the ori,
which contains binding sites for both proteins (Li et al., and utilizes the adenovirus major late promoter to drive
expression of E2 (Barsoum et al., 1992). Cysteine 3401989; Mohr et al., 1990; Blitz and Laimins, 1991; Lusky
and Fontane, 1991; Ustav et al., 1991, 1993; Yang et al., mutants were transferred as KpnI/BstXI fragments from
the yeast expression vectors to pBG331 and sequenced.1991; Seo et al., 1993). The E1 protein is sufficient to
support viral DNA replication in vitro, but replication is The entire E2 gene from pBG331E2 was transferred to
the pCGE2b plasmid. pCGE2b was modified frommarkedly stimulated by the addition of E2 protein (Yang
et al., 1991; Bonne-Andrea et al., 1995). For significant pCGE2, kindly provided by A. Stenlund, to contain a
BamHI site in the polylinker and encodes the wild-typereplication levels in vivo, both the E1 and the E2 proteins
are required (Ustav and Stenlund, 1991; Yang et al., 1991; methionine codon (nt 3089) of E2TR. For nuclear localiza-
tion studies, the 12-aa simian virus 40 (SV40) nuclearUstav et al., 1993). E2 may function in replication in part
by promoting the interaction of E1 with specific sites in localization signal (Ala Pro Lys Lys Lys Arg Lys Val Glu
Asp Pro Ala) was inserted into the KpnI site of the E2the viral origin.
Recognition of and binding to E2-specific binding sites gene (nt 3456). Plasmids used for replication assays in-
cluded the pCGEAG plasmid which contains the E1 geneis thought to be critical to both viral transcription and
replication. We hypothesized that the cysteine in the ba- in the pCG vector, the pCGE2b plasmid described above,
and pBPV-LCR which contains the 1462-bp HindIII– PstIsic helix had been maintained in PV evolution because
it provides a function(s) important in E2-directed replica- (nt 6959–470) fragment of BPV-1 inserted into the corre-
sponding sites of pUC19 (Ustav and Stenlund, 1991;tion or transcription. Interestingly, other viral and cellular
proteins contain basic DNA-binding regions which share Sverdrup and Khan, 1994). The VP16 and E2 chimeras,
pVE2, pVE2S, pVE2G, and pVE2F, were made by deletinghomology with the basic binding region of E2 and which
also contain a cysteine homologous to 340-C in BPV-1 aa 1–282 (nt 2608–3458) of E2 and replacing them with
aa 1–80 of the VP16 transactivation domain in theE2 (Bannister et al., 1991; McBride et al., 1992; Xanthou-
dakis et al., 1992). The homology of the E2 binding-region pBG331 vectors. Several reporter constructions were
used to evaluate E2 transactivation in mammalian cellcysteine with the cysteine of the transactivators Fos, Jun,
BZLF1, and ATF-2 suggested that this residue may be lines. pXB332 human growth hormone (hGH) reporter
contains a truncated SV40 early promoter, three up-involved in the transcription function of E2. This notion
is supported by recent results which show that important stream E2-binding sites, and the hGH gene (pTKGH; Alle-
gro hGH gene expression kit, Nichols Institute) and isprotein–protein interactions of activating proteins occur
through the DNA-binding regions of these proteins. In described elsewhere (Barsoum et al., 1992). pURRGH
reporter includes the BPV upstream regulatory regionaddition, recent data indicate that the C-terminal region
of E2 binds both TATA-binding protein (TBP) and TFIIB enhancer and hGH. The pMJG1 reporter was made by
inserting three E2-binding sites (ACCGAATTCGGT) into(Rank and Lambert, 1995). To study the role of the E2
DNA-binding region in E2-directed transcription and rep- the HindIII/NdeI sites upstream of the TK promoter ele-
ments and hGH gene in pTKGH.lication we created point mutations at the conserved cys-
teine residue and tested the ability of these mutants to
activate E2-dependent transcription and to support tran- Mammalian cell transfections and
sient replication. immunofluorescence
Approximately 3–5 1 106 cells were grown to 50%MATERIALS AND METHODS
confluence and trypsin released cells were electropor-
Mutagenesis of cysteine-340, expression of C-
ated with a Bio-Rad Gene Pulser. COS-7 cells were elec-
terminal E2 proteins, and construction of plasmids
troporated at 0.25 kV and 960 mFD, Chinese hamster
ovary (CHO) cells at 0.28 kV and 960 mFD, and NIH 3T3Site-directed mutagenesis was performed to change
the cysteine codon at amino acid 340 in BPV-1 E2 to cells at 0.24 kV and 960 mFD. Under these conditions
30–50% of the cells stained blue when exposed to X-serine (AGC and TCC), glycine (GGC), and phenylalanine
(TTC) using degenerate oligonucleotides. Mutated se- gal on Day 3 posttransfection using an SV40-based lacZ
gene. Electroporations into COS-7, CHO, and NIH 3T3quences were transferred as a KpnI/BstXI fragment [nu-
cleotides (nt) 3456–3882] into an Saccharomyces cere- cell lines introduced 20 mg of reporter plasmid, 20 mg of
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effector plasmid, and 360 mg of salmon sperm DNA.
These conditions and input DNA concentrations were
determined to be optimal for COS-7 cell electroporations
and were reported previously (Barsoum et al., 1992).
COS-7 and CHO cells were fed with fresh medium 24 hr
postelectroporation. C-33A cells were transfected with
500 ng of the expression plasmid and 1 mg reporter plas-
mid by calcium phosphate coprecipitation as described
previously (Sverdrup and Khan, 1994). Medium was as-
sayed for hGH at Day 3 posttransfection. For immunofluo-
rescence, cells were rinsed 21 with phosphate-buffered
saline (PBS), fixed in 4% paraformaldehyde in PBS with
10% fetal calf serum, and permeabilized 10 min in 0.2%
Triton X-100 in PBS. Polyclonal anti-E2 antiserum was
applied for 30 min at 377 followed by fluorescein-conju-
gated anti-rabbit antiserum for 30 min at 377.
Analysis of E2 proteins by Western blot and
electrophoretic mobility shift assays (EMSA)
FIG. 1. Trans-activation by wild-type E2 and E2 340 mutants in COS-To identify E2 proteins, cell extracts were separated
7 cells. Plasmid pBG331 carrying wt E2, E2 340-S or 340-G, 340-F, oron a 10% polyacrylamide denaturing gel and transferred
vector alone were electroporated into COS-7 cells with an E2-depen-to Immobilon (NEN). Blots were developed as described
dent human growth hormone (hGH) reporter and media were assayed
previously using either polyclonal antiserum or mono- for hGH.
clonal B202 (Morrissey et al., 1989). For in vivo dimeriza-
tion assays COS-7 cells were electroporated with
RESULTSpBG331E2 plasmids as described above. At 3 days post-
electroporation, medium was removed from the cell Transcriptional properties of BPV-1 E2 340 mutants in
monolayer and attached cells were irradiated with mammalian cells
320,000 mJ of UV light in a Stratalinker. Cells were ex-
The evolutionary conservation of cysteine in the E2tracted, soluble proteins loaded onto 10% polyacrylamide
DNA contact region of most papillomaviruses and sev-gels, and immunoblots performed as described above.
eral viral and cellular transcriptional activating proteinsCOS cell extracts for EMSA were prepared as described
implies that it serves a specific function. To study the roleabove. Nuclear extracts were diluted to 1 or 2 M urea
of this conserved cysteine in transactivation, we createdfor DNA-binding assays, and binding reactions were per-
point mutations at aa 340, converting the cysteine in BPV-formed using a radiolabeled E2-binding site probe (5*
1 to serine (340-S), glycine (340-G), and phenylalanineACCGAATTCGGT 3* ) as previously described (Prakash
(340-F). The phenylalanine mutation introduces a bulkyet al., 1992).
hydrophobic group to the binding helix and has been
shown previously to be unable to bind DNA, a property
DNA replication assays of E2 necessary for transactivation (Barsoum et al., 1992).
The E2 340 mutations were cloned into mammalian ex-
C-33A cells were transfected with 3 mg pCGEAG plas- pression vectors and tested with reporter constructs that
mid, 1 mg of pCGE2 plasmid, and 500 ng pBPVLCR plas- contained three E2 binding sites in the 5* flanking region
mid. Three days posttransfection, Hirt fractions con- of either the minimal SV40 promoter (NIH 3T3 cells) or the
taining the low-molecular-weight DNA were isolated and TK promoter (CHO and COS-7 cells) and which regulate
a Southern blot was performed as previously described expression of the hGH reporter gene. Data compiled from
except for the use of a random primed, DIG-labeled three individual COS-7 cell experiments are summarized
pUC19 probe (Genius system, Boehringer-Mannheim) in Fig. 1 and demonstrate that transcriptional activities
(Sverdrup and Khan, 1994). of E2 340-S and E2 340-G were at levels approximately
equal to the vector-only control. In addition to experi-
ments in COS cells, these mutants were found to beYeast assays for trans-activation
transactivation defective in CHO, NIH 3T3, and C-33A
cell lines. These mutants were transactivation defectiveYeast strain BGW 1-7a was transformed by standard
lithium acetate procedure and b-gal assays were carried when tested on three different E2-dependent reporter
constructs, pURRGH, pXB332 hGH, and pMJG1. As ex-out according to standard protocols (Morrissey et al., 1989).
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FIG. 2. E2 proteins from transfected COS-7 cell extracts. (A) Western blot of transfected COS cell extracts probed with monoclonal antibody.
Equal volumes of COS-7 cell extract were loaded in each lane. The E2 signal shows two E2-specific bands when probed with either polyclonal or
monoclonal antibody. (B) Mobility shift assay of E2-transfected COS cell extracts. A DNA probe containing one E2 binding site was 32P-labeled and
incubated with fractionated COS-7 cell extracts to assay DNA binding ability of the E2 proteins. (C) Western blot of COS-7 cells transfected with
pBG331 E2, 340-S, or 340-G mutants. At Day 3 posttransfection media were removed and cells exposed as a monolayer to UV light. Equal volumes
of UV-exposed cell extracts were loaded onto a 10% polyacrylamide gel and Western blots performed.
pected, the DNA-binding defective mutant 340-F was troporated COS-7 cells were analyzed by mobility shift
also unable to activate transcription in all cell lines tested assay. A representative assay showing binding abilities
and with all reporters used (Fig. 1). To eliminate the pos- of the wild-type and mutant E2 proteins in COS-7 cell
sibility that E2 340-S and 340-G were defective due to extracts is shown in Fig. 2B. In these mobility shift
an unrecognized vector artifact, the C-terminal wild-type assays, approximately equal E2 protein amounts, as de-
E2 segment from KpnI to BstXI was cloned into the 340- termined by immunoblot, were added to each binding
S and 340-G vector constructs and resulted in full restora- reaction. Extracts containing wt E2 and E2 340-G bound
tion of E2 transcriptional activity. 340-S and 340-G ex- the E2 DNA-binding site probe with approximately equal
pression vectors were titrated and found to be inactive affinity, while 340-S containing extracts showed a de-
over a range (10–40 mg) of input DNA at which wild-type crease in DNA binding and 340-F was unable to bind
E2 remained active. To compare wild-type and mutant DNA. Together, these results show that 340-C is not re-
E2 protein levels, COS-7 cells were electroporated with quired for DNA binding of the E2 protein although substi-
equal amounts of wt E2, E2 340-S, E2 340-G, or pBG331 tution to 340-S does decrease DNA binding in mamma-
vector. Cells were harvested in SDS denaturing buffer lian cell extracts.
3 days postelectroporation and total cell extracts were
examined by immunoblot. In Fig. 2A, equal volumes of In vivo dimerization of E2 proteins
whole cell extract were loaded per lane and approxi-
mately equal amounts of full-length protein were de- While positive DNA-binding results imply that the 340
tected in wt E2, E2 340-S, and E2 340-G transfected cells. mutant proteins were capable of self-association, we
We consistently detect the E2 protein as a doublet on were able to take advantage of a unique assay to directly
SDS/PAGE gels. In experiments described later, which test dimerization in vivo. Previous studies with bacterially
involve the insertion of the 12-aa SV40 nuclear localiza- expressed E2 peptides have shown that multiple amino
tion signal (NLS) into the E2 coding sequence, we see acids throughout the minimal C-terminal domain are im-
a corresponding decrease in the mobility of both bands, portant for dimerization (Prakash et al., 1992). Among
confirming that both are encoded by the E2 open reading these the tryptophan residue at aa 360, conserved among
frame. E2 degradation products were observed migrating the papillomaviruses, contributes to stable dimerization
faster than the E2 protein. These immunoblots demon- (Corina et al., 1993). The close proximity of the 360 trypto-
strate that the inability of the E2 340-S and 340-G proteins phan residues contributed by each monomer generates
to activate transcription was not due to lack of synthesis a zero order cross-link of the dimers in solution after
or to rapid degradation of the mutant proteins. irradiation with ultraviolet light (Prakash et al., 1992). COS
DNA-binding capability of in vivo synthesized E2 cells were electroporated with pBG331E2, pBG331E2
proteins 340-S, pBG331E2 340-G, and pBG331E2 340-F plasmids,
and attached cells were exposed as a monolayer to UVTo test the ability of the E2 340 mutants to bind E2
DNA sites, nuclear and cytoplasmic fractions from elec- light and harvested in SDS denaturing buffer. A represen-
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tative immunoblot of the cross-linked E2 proteins is protein was detected by Western blot at levels approxi-
mately equal to that of pVE2 wt (data not shown). Thisshown in Fig. 2C. Although not quantitative, comparison
of the relative levels of dimer to monomer for wt and result is consistent with the inability of 340-F to bind
DNA (Fig. 2B) and provides evidence that the pVE2S andmutant proteins confirmed that both E2 340-S and 340-
G formed stable dimers in vivo (Fig. 2C) as did 340-F pVE2G activities are not due to nonspecific transactiva-
tion by the VP16 activation domain. pVE2S showed an(data not shown).
approximate sevenfold decrease in transcriptional activ-
E2 wild-type and mutant proteins are differentially ity compared to wild type, while pVE2G showed an ap-
localized proximately fourfold decrease. The VP16-E2 wt chimera
was more active with our reporter constructs than the
The inability of mutant proteins to activate transcription
full-length E2 wt. Since the 340-S and 340-G mutants
could be due to a defect in localization to the nucleus.
gave reduced activities compared to the wt E2-VP16 chi-
We observed by immunofluorescence that while the ma-
mera (14 and 21% of wt, respectively), a corresponding
jority of wild-type E2 localized to the nucleus, the 340-S
decrease in their activities in the context of full-length
and 340-G proteins appeared both in the nucleus and in
E2 proteins might result in inability to detect their stimula-
the cytoplasm. The binding-defective mutant, 340-F, was
tion in our assays. However, analysis of our results indi-
also found to localize in a pattern similar to that of 340-
cates that activities of 14 and 21% of wt E2 would be
S and 340-G. The pattern of staining was observed using
significantly above background and would be detected.
both monoclonal (data not shown) and polyclonal anti-
These E2–VP16 fusion experiments confirm that the 340-
sera (Fig. 3). The NLS of E2 has not been determined
S and 340-G E2 domains are able to carry out the known
and therefore it was possible that the 340 mutations were
C-terminal functions of DNA binding and E2 dimerization
disturbing an E2 NLS and as a consequence were unable
on an active promoter.
to activate transcription. In an attempt to direct the cyto-
plasmic E2 proteins into the nucleus, the 12-amino-acid The 340 mutants activate transcription in yeast
NLS of SV40 large T was inserted in frame into the ‘‘hinge’’
region of wild-type and mutant E2 genes. This region E2 has been shown to activate transcription in yeast
(Lambert et al., 1989; Morrissey et al., 1989). To test thewas chosen because it is not conserved among the PVs
and is not necessary for E2 trans-activation (Giri and ability of these 340 mutants to trans-activate in a yeast
system, full-length E2 coding sequences containing ei-Yaniv, 1988; Winokur and McBride, 1992). The NLS did
not interfere with wild-type E2 protein levels or its ability ther wt or the 340 mutations were cloned into the 2m
expression vector pKP-15, in which expression of E2 isto activate the target promoter. As judged by both immu-
nofluorescence and cell fractionation followed by immu- regulated by the GAL1-10 UAS. Yeast strains carrying
either wild-type or mutant E2 expression plasmids alongnoblot (not shown), addition of the NLS to the 340 muta-
tions resulted in increased nuclear E2 protein with a with an E2-dependent lacZ reporter were used to test E2
transcription function. As shown in Fig. 5, the 340-S andconcomitant decrease in cytoplasmic E2 protein (Fig. 3).
Despite the abundant amounts of E2 340-S/NLS and 340-G E2 mutants activated transcription to near wild-
type levels in yeast as determined by quantitative b-gal340-G/NLS redistributed to the nucleus, these proteins
remained unable to stimulate the E2-dependent promoter assays. Consistent with its inability to bind DNA, 340-F
showed no activity. One possible explanation of the activ-(data not shown).
ity of 340-S and 340-G in yeast is that the mutants are
Chimeric VP16/E2 proteins can activate transcription temperature sensitive. To evaluate if 340-S and 340-G
were temperature sensitive mutants, yeast were
The preceding experiments did not explain the inability
switched to 377 upon galactose induction. Under these
of 340-S and 340-G to activate transcription. To test in
conditions expression of the b-Gal reporter was compa-
vivo the ability of these mutated DNA-binding domains
rable to levels measured at 307 (data not shown). Simi-
to access and activate E2-binding sites in a promoter
larly, CHO and COS-7 cells transfected with E2 340-S
complex, chimeras of the trans-activation domain of the
and 340-G failed to stimulate the target reporter at both
herpesvirus VP16 gene with the wild-type and mutat-
37 and 327 (data not shown). The activity of the mutant
ed BPV-1 E2 DNA-binding domains were generated.
proteins in a yeast system provides further evidence that
pVE2wt, pVE2S, pVE2G, and pVE2F were electroporated
these E2 mutant proteins can be synthesized in a tran-
into COS-7 cells and hGH activity from the E2 responsive
scriptionally competent context.
reporter plasmid pMJG1 was measured. The results of
three individual assays are summarized in Fig. 4. These E2 340-S and 340-G support transient DNA
data indicate that 340-S and 340-G containing C-terminal replication
domains were able to support activation with a heterolo-
gous activation domain. Of interest, the 340-F chimera It has previously been shown that the full-length prod-
ucts of the E1 and E2 ORFs are both necessary for BPV-did not activate transcription of the reporter, although
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FIG. 3. Immunofluorescent localization of E2 in COS-7 cells. COS-7 cells transfected with the pBG331 vector carrying (A) wt E2, (B) E2 340-S, (C)
E2 340-G, (D) E2 340-F, (E) pBG331 vector, (F) E2 340-S /NLS, (G) E2 340-G/NLS, or (H) E2 340-F/NLS. Cells were probed with polyclonal E2
antibody and anti-rabbit fluorescein. The SV40 nuclear localization signal was inserted at the KpnI site of these E2 coding sequences.
1 transient DNA replication in C127 cells (Ustav and Sten- LCR plasmid to approximately equal levels. These results
demonstrate that cysteine 340 is not required for thelund, 1991). To test the trans-activation defective 340 mu-
tants for function in transient in vivo replication assays, replication function of E2. Both E2 340-S and 340-G re-
mained unable to activate transcription in parallel experi-E2 340-S, 340-G, and 340-F mutants were cotransfected
with BPV-1 E1 and LCR containing plasmids into the ments when cotransfected with the pMJG1 reporter in
C33-A cells. Interestingly, although pCG340-F is unableHPV-negative human cervical cell line C33-A. Hirt ex-
tracts were prepared 3 days posttransfection and the to bind DNA or to transactivate, it repeatedly stimulated
DNA replication, although levels were reduced comparedDNA was digested with EcoRI to linearize the plasmids.
Half of each sample was digested with DpnI to differenti- to wild-type E2.
ate replicated from input DNA. The autoradiogram in Fig.
DISCUSSION6, representative of four independent experiments,
shows that the vectors expressing E2 340-S and 340-G To better understand the contribution of the E2 C-ter-
minal region in viral transcription and replication we cre-as well as wild-type E2 all stimulated replication of the
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FIG. 6. Transient replication in C33-A cells. C33-A cells were
transfected with plasmids containing E1 and E2wt or E2 340-S, 340-G,
or 340-F and pBPVLCR by calcium phosphate coprecipitation. Cells
were harvested, DNA was isolated, and Southern blots were performed.
DNA-binding domains of the bZIP family and of the Ep-
stein–Barr virus trans-activating protein BZLF1 show ho-
mology to the binding domain of E2 and contain a cys-
teine analogous to 340 cysteine (McBride et al., 1992;
Xanthoudakis et al., 1992). Because the DNA-binding do-FIG. 4. Transcriptional activity of VP16/E2 fusions. (A) Plasmids
main of E2 is involved in both transcription and replica-pVE2wt, pVE2S, pVE2G, pVE2F, or vector were electroporated into COS-
7 cells with an E2-dependent human growth hormone (hGH) reporter tion an understanding of the mechanisms of E2 function
construct and media were assayed for hGH. in these processes requires analysis of the C-terminal
domain.
The DNA-binding region cysteine of BPV-1 E2 isated point mutations in this region of BPV-1 E2. The cys-
shown here to be required for transcriptional activityteine at position 340 in BPV-1 E2 in the center of the
in four distinct cell lines using three different reporterDNA-binding helix makes direct contacts to DNA and is
constructs containing variations in number of and spac-highly conserved among PV E2 proteins (Hegde et al.,
ing between E2-binding sites. In vivo E2 340-S and 340-1992; McBride et al., 1992; Prakash et al., 1992). The
G were expressed as stable proteins, were dimeriza-
tion and DNA binding competent, and were capable of
localizing to the nucleus. The transcriptional activity of
these same mutants in S. cerevisiae demonstrates that
these mutant proteins are capable of proper folding in
yeast. Furthermore, the 340-S and 340-G E2 mutants
fully supported viral replication and therefore must be
able to assume a conformation functional for replica-
tion in mammalian cells.
The transactivation defect of the mutants could not be
ascribed to an inability to bind DNA. Both mutants bound
DNA although the 340-S protein from transfected COS
cell extracts showed a reduced binding compared to the
binding of wt E2 and E2 340-G. Neither was the lack of
transcriptional activity of 340-S and 340-G attributable to
a dimerization defect. Using a unique UV cross-linking
assay, both the 340-S and the 340-G containing proteins
formed dimers in vivo. It has been shown that the E2 340
cysteine and the analogous cysteines in Fos and Jun
confer upon these proteins oxidation/reduction-sensitive
DNA binding in vitro (Abate et al., 1990; McBride et al.,
1992; Androphy and Pepinsky, unpublished observa-
tions). In the studies with Fos and Jun, mutations of this
FIG. 5. Trans-activation by wild-type E2 and E2 mutants in yeast.
cysteine resulted in increased DNA-binding activity. InYeast strain BGW1-7a was transformed with the expression vector pKP-
contrast, our results and those of McBride demonstrate15 and an E2-dependent lacZ reporter. Quantitative b-gal assays were
performed and results are expressed as percentages of E2wt. that E2 340 mutants bind DNA with less affinity than
AID VY 7781 / 6a12$$$$21 02-02-96 15:29:07 vira AP: Virology
308 GROSSEL ET AL.
wild type in vitro and the 340-S mutant shows decreased (Winokur and McBride, 1992). In contrast to data pre-
sented here, using different E2 DNA-binding mutations,binding affinity when tested in transfected cell extracts.
Although there has been no evidence of binding regula- Ustav et al. demonstrated that the ability of E2 to support
DNA replication was proportional to its DNA-binding ac-tion through a redox mechanism in vivo, we cannot rule
out the possibility that a redox mechanism could regulate tivity as measured using a single E2-binding site probe
(Ustav et al., 1993).E2 DNA binding in vivo through the 340 cysteine.
Our results indicate that 340-C may influence cellular E2 fusion proteins containing the 340-S and 340-G
mutations allowed the VP16 TAD to activate the E2-bind-localization. Immunofluorescence studies showed that
340 mutant proteins showed a substantial cytoplasmic ing site reporter, although both chimeras showed de-
creased activity compared to the wild-type chimera. Thefraction in addition to the nuclear compartment in which
wtE2 was predominately localized. Similarly, Chida and DNA-binding defective mutant 340-F produced stable
protein but did not support VP16-mediated transactiva-Vogt showed the cellular localization of c-Jun was distin-
guishable from that of v-Jun. Nuclear localization of c- tion, demonstrating that the activity of the 340-S and 340-
G fusions to VP16 was not due to nonspecific activationJun is cell cycle independent while v-Jun is translocated
to the nucleus in a cell-cycle-dependent manner. This by the VP16 domain. These data suggest that 340-C is
required specifically for activation by the full-length E2cell-cycle dependence of nuclear translocation was
mapped to a cysteine (c-Jun) to serine (v-Jun) mutation protein and not for activity directed by the VP16 activation
domain. Thus, E2 is not strictly a modular protein within the basic DNA-binding domain (Chida and Vogt, 1992).
Interestingly, the DNA-binding domain and central cys- distinct transcription and DNA-binding domains because
a residue in the DNA-binding domain is required for E2teine of Jun are analogous to the binding domain of BPV-
1 E2 and its central (340) cysteine. Even when the SV40 trans-activation. The cysteine in the binding domain may
provide a necessary function which is required in someNLS was cloned into the hinge region of the E2 ORF,
and the 340 mutant proteins resided primarily in the nu- transcriptional activating proteins (E2), but circumvented
in other trans-activating proteins such as VP16. It is un-cleus, they remained unable to activate transcription.
Thus, while it is likely that the 340 mutations disrupt an likely that the 340-C is required only for an intramolecular
(E2–E2) interaction since such a defect would be ex-important NLS, the inability of these proteins to activate
transcription is not due to nonnuclear localization. One pected to occur in yeast, where the 340 mutants retain
their transcriptional activity. The activity of the 340 mu-interesting possibility is that this DNA-binding region cys-
teine is necessary to address E2 to the proper nuclear tants in yeast and lack of activity in mammalian cells
suggest that there may be additional or separate require-compartment for transcription in mammalian cells. Of
note, both the 340-S and the 340-G E2 mutants replicated ments or mechanisms for transcription in the natural PV
host, mammalian cells, that are not present in yeast.the LCR plasmid to approximately wild-type levels, while
the DNA binding defective mutant 340-F showed reduced Because these mutants are transcriptionally active in
yeast but not mammalian cells, yet do support replicationreplication. Competence in this in vivo replication assay
suggests that these mutant E2 proteins were able to in C33-A cells, we speculate that 340-C is required for
an intermolecular interaction with a mammalian-specificassume the proper conformation required for replication,
including interaction with the E1 protein, and were prop- cellular transcription factor.
The DNA-binding domains of several transcription fac-erly localized to the nucleus. Interestingly, Pombo et al.
have shown that the sites of adenovirus transcription tors have recently been shown to mediate protein–pro-
tein interactions important for transcription. The cellularand replication are spatially separated within the nucleus
(Pombo et al., 1994). These studies provide one possible transactivating protein, SP1, interacts through its DNA-
binding domain with human TAFII55, a TBP-associatedexplanation of the differential ability of the 340 mutants
to stimulate replication but not activate transcription. factor (Chiang and Roeder, 1995). Liu and Green have
shown that the adenovirus E1a protein interacts specifi-These point mutations at cysteine 340 discriminate
the transcription and replication functions of E2. This is cally with the DNA-binding domains of several cellular
transcription factors (Liu and Green, 1994). Remarkably,consistent with previous studies which also demon-
strated that these E2 functions are separable (Alderborn these cellular factors include ATF-1, ATF-2, ATF-3, and
c-Jun, which all share homology with the basic bindinget al., 1992; Winokur and McBride, 1992). However, the
requirement for cysteine 340 in transcriptional activation domain of E2 and contain a homologous cysteine resi-
due. Finally, the association of the Drosophila Kruppelbut not replication likely reflects a novel property of the
E2 protein. The DNA-binding defective mutant E2 340-F (Kr) protein with TFIIB and TFIIEb requires the presence
of Kr-binding sites (Sauer et al., 1995). This suggests thatwas able to support low-level replication, suggesting that
DNA binding is not absolutely required but enhances only DNA-bound Kr is capable of these interactions and
implicates the DNA-binding domain of this transcriptionalreplication. This conclusion is consistent with previously
published in vitro replication data with E2 340-F (Li et regulator in direct interaction with components of the
basal RNA pol II transcription machinery. It has recentlyal., 1993) and with an in vivo study of E2 replication
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containing a protease resistant core interacts with its DNA target.been shown that the DNA-binding region of E2 directly
EMBO J. 7, 3807–3816.binds both TBP and TFIIB (Rank and Lambert, 1995).
Giri, I., and Yaniv, M. (1988). Structural and mutational analysis of E2Although this binding may be required for transactivation, trans-activating proteins of papillomaviruses reveals three distinct
it is not sufficient for E2TA’s strong trans-activating activ- functional domains. EMBO J. 7, 2823–2829.
ity since this region is shared among the repressing and Ham, J., Dostatni, N., Arnos, F., and Yaniv, M. (1991). Several different
upstream promoter elements can potentiate transactivation by theactivating E2 proteins. These data and our own results
BPV-1 E2 protein. EMBO J. 10, 2931–2940.lend support to a model in which 340-C is required for
Haugen, T., Turek, L., Mercurio, F., Cripe, T., Olson, B., Anderson, R.,a protein–protein interaction with a cellular factor neces-
Seidl, D., Karin, M., and Schiller, J. (1988). Sequence-specific and
sary for activated transcription but not E2-stimulated rep- general transcriptional activation by the bovine papillomavirus-1 E2
lication. Studies have shown that functional interactions trans-activator require an N-terminal amphipathic helix-containing
E2 domain. EMBO J. 7, 4245–4253.between E2 and the cellular activating proteins SP1 and
Hawley-Nelson, P., Androphy, E. J., Lowy, D., and Schiller, J. (1988). TheUSF allow activated transcription by E2 (Ham et al., 1991;
specific DNA recognition sequence of the bovine papillomavirus E2Li et al., 1991; Ushikai et al., 1994). The region(s) of E2
protein is an E2-dependent enhancer. EMBO J. 7, 525–531.
involved in these protein –protein interactions with SP1 Hegde, R., Grossman, S., Laimins, L., and Sigler, P. (1992). Crystal
and USF remains unidentified. We are now using these structure at 1.7A of the bovine papillomavirus-1 E2 DNA-binding do-
340 mutants to identify cellular proteins which may di- main bound to its DNA target. Nature 359, 505–512.
Lambert, P., Dostatni, N., McBride, A., Yaniv, M., Howley, P., and Arcan-rectly or indirectly require the presence of cysteine in
gioli, B. (1989). Functional analysis of the papilloma virus E2 trans-the DNA-binding helix of E2.
activator in Saccharomyces cerevisiae. Genes Dev. 3, 38–48.
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